First Gene Therapy for Genetic Hearing Loss Approved

Ebselen as a ray of hope
Picture: Herney Gomez pixabay.com

So far, hearing loss related to genetics is treated the way any other type and degree of hearing loss are treated. Why? Because specific therapies to correct or replace defective or missing genes that interfere with the development of hearing structures and/or their functions are not available. But that changed recently, and there is hope for more progress in the future.

Hopeful yet cautious celebration of a significant breakthrough

On April 23, 2026, the FDA announced the first and so far, only  FDA-approved gene therapy for a rare type of gene-related severe hearing loss and deafness. The condition is due to mutations on a specific gene – OTOF. This gene gives the detailed instructions for producing a protein called “otoferlin.” Otoferlin enables communication between the inner-ear hearing cells and the hearing (cochlear) nerve. Without otoferlin, sound signals do not reach the brain and people do not hear.

Known as Otarmeni, OTOF therapy is a huge step forward with documented positive results. New insights gained from the OTOF research will serve as steppingstones for scientists as they work on these very complicated issues. Might the next breakthrough involve therapy for mutations of the GJB2 gene that lead to a much more common hereditary deafness referred to as “Connexin 26?” Although the challenges are much greater than those for OTOF, progress is being made. 

Family ties and hearing history: Every detail counts!

About 90% of babies born deaf or hard of hearing are born to hearing parents who are often taken totally by surprise. Hearing issues are usually first diagnosed during Newborn EHDI (Early Hearing Detection and Intervention) tests. If the baby does not pass the initial tests, further diagnostic evaluations follow and the family hearing history will also be reviewed. During pregnancy a variety of problems can affect the development and function of the hearing structures. However, genetic mutations or missing genes are responsible for more than 50% of congenital (present at birth) deafness or serious hearing loss cases. But which gene is involved? One? More? Parents often decide to be genetically tested for their own information, which will also benefit the child as they move along in life. As an added plus, scientists get much-needed data that help further this important research.

Genetic therapy is not a one-fits-all – or most – scenario

According to the NIDCD (National Institute on Deafness and other Communication Disorders) more than 150  hearing loss related genes have been identified. It looks like every gene will need its specific designer therapy and way of delivering the corrected or missing version of the gene to the correct site. This is indeed slow, tedious, very precise and very expensive work. It will take time! Then again, might this be an area where AI could help organize and speed up the process? 

Yes, genetics matter but so do Lifestyle choices

Nobody knows about all the hidden weak links in their systems. Yes, genetic hearing loss can be present at birth (congenital). However, genetics may also play a part in hearing loss that manifests itself at any stage throughout life – later in childhood or in early adulthood. Who knows? Researchers rightfully warn not to underestimate the importance of environmental factors and lifestyle choices. Might they become the sparks that aggravate or set off genetic weaknesses?

It turns out that some underlying genetic factors can impact age-related hearing loss while others can make the hearing system more sensitive to external triggers, such as the effects of loud sound. Such repeated and prolonged exposures lead to Noise-induced hearing damage and hearing loss. This is often described as a premature and accelerated aging of the ears. And so, our “sound” choices could indeed work against us. Caution is the word! When in doubt and in the absence of a cure, prevention is the way to go.

…Neither swift nor easy…

In the end, 2026 will always be remembered for the first FDA-approved gene therapy for genetic hearing loss. There is more to follow, for sure. But we need patience. That is the way of science. Marie Curie, pioneering researcher and scientist, spoke the truth when she remarked:” I was taught that the way of progress is neither swift nor easy.”

Categories